The initial product is a sealant patch providing rapid hemostasis for abdominopelvic and orthopedic procedures, according to a May 12 news release from Sealonix. The proceeds from the round will be used to grow the development team and execute clinical trials.
The funding round was led by Excelestar Ventures.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
